11.05
price down icon4.99%   -0.58
pre-market  Pre-market:  11.30   0.25   +2.26%
loading
Cvrx Inc stock is traded at $11.05, with a volume of 108.93K. It is down -4.99% in the last 24 hours and down -23.74% over the past month. CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
See More
Previous Close:
$11.63
Open:
$11.6
24h Volume:
108.93K
Relative Volume:
0.50
Market Cap:
$287.70M
Revenue:
$47.26M
Net Income/Loss:
$-58.48M
P/E Ratio:
-4.0852
EPS:
-2.7049
Net Cash Flow:
$-40.45M
1W Performance:
-4.58%
1M Performance:
-23.74%
6M Performance:
+40.76%
1Y Performance:
-49.47%
1-Day Range:
Value
$10.93
$11.63
1-Week Range:
Value
$10.76
$11.96
52-Week Range:
Value
$6.40
$22.45

Cvrx Inc Stock (CVRX) Company Profile

Name
Name
Cvrx Inc
Name
Phone
(763) 416-2850
Name
Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Name
Employee
206
Name
Twitter
Name
Next Earnings Date
2025-02-04
Name
Latest SEC Filings
Name
CVRX's Discussions on Twitter

Compare CVRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
CVRX
Cvrx Inc
11.05 287.70M 47.26M -58.48M -40.45M -2.7049
Medical Devices icon
ABT
Abbott Laboratories
129.89 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.37 140.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
363.66 138.77B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
92.33 118.39B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
67.95 39.95B 5.72B 4.17B 259.90M 6.97

Cvrx Inc Stock (CVRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-14-25 Upgrade William Blair Mkt Perform → Outperform
Sep-10-24 Initiated Cantor Fitzgerald Overweight
Jul-11-24 Reiterated Lake Street Buy
May-01-24 Resumed Craig Hallum Buy
May-01-24 Downgrade JP Morgan Overweight → Neutral
May-01-24 Downgrade William Blair Outperform → Mkt Perform
Jan-31-23 Initiated Lake Street Buy
Jul-18-22 Initiated Craig Hallum Buy
Jul-26-21 Initiated Canaccord Genuity Buy
Jul-26-21 Initiated Piper Sandler Overweight
Jul-26-21 Initiated William Blair Outperform
View All

Cvrx Inc Stock (CVRX) Latest News

pulisher
Mar 09, 2025

(CVRX) Trading Report - Stock Traders Daily

Mar 09, 2025
pulisher
Mar 07, 2025

With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For - Simply Wall St

Mar 07, 2025
pulisher
Mar 05, 2025

Power Shift 25: Medtech firm's new CEO looks to 'build a world-class team' - The Business Journals

Mar 05, 2025
pulisher
Feb 25, 2025

CVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Feb 25, 2025
pulisher
Feb 24, 2025

Analyzing Co-Diagnostics (NASDAQ:CODX) and CVRx (NASDAQ:CVRX) - Defense World

Feb 24, 2025
pulisher
Feb 19, 2025

CVRx, Inc. (NASDAQ:CVRX) Short Interest Down 9.8% in January - Defense World

Feb 19, 2025
pulisher
Feb 18, 2025

CVRx, Inc. SEC 10-K Report - TradingView

Feb 18, 2025
pulisher
Feb 17, 2025

CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

CVRx's SWOT analysis: barostim maker's stock faces reimbursement hurdles By Investing.com - Investing.com UK

Feb 17, 2025
pulisher
Feb 16, 2025

(CVRX) Long Term Investment Analysis - Stock Traders Daily

Feb 16, 2025
pulisher
Feb 13, 2025

CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim - GlobeNewswire

Feb 13, 2025
pulisher
Feb 12, 2025

Cvrx, Inc. Announces New Real-World Evidence Demonstrating Significant Reductions in Healthcare Utility with Barostim - Marketscreener.com

Feb 12, 2025
pulisher
Feb 12, 2025

CVRx, Inc. Presents New Real-World Evidence Demonstrating Significant Reductions in Hospital Visits After Barostim Implantation at THT Conference 2025 - Nasdaq

Feb 12, 2025
pulisher
Feb 12, 2025

Institutional owners may take dramatic actions as CVRx, Inc.'s (NASDAQ:CVRX) recent 10% drop adds to one-year losses - Simply Wall St

Feb 12, 2025
pulisher
Feb 11, 2025

CVRx (CVRX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - MSN

Feb 11, 2025
pulisher
Feb 11, 2025

Cantor Fitzgerald Has Negative View of CVRx FY2025 Earnings - MarketBeat

Feb 11, 2025
pulisher
Feb 11, 2025

William Blair Weighs in on CVRx's Q2 Earnings (NASDAQ:CVRX) - MarketBeat

Feb 11, 2025
pulisher
Feb 09, 2025

Piper Sandler Forecasts Strong Price Appreciation for CVRx (NASDAQ:CVRX) Stock - MarketBeat

Feb 09, 2025
pulisher
Feb 08, 2025

CVRx (NASDAQ:CVRX) Price Target Raised to $23.00 at Canaccord Genuity Group - MarketBeat

Feb 08, 2025
pulisher
Feb 08, 2025

Wall Street Analysts Predict a 25.76% Upside in CVRx (CVRX): Here's What You Should Know - MSN

Feb 08, 2025
pulisher
Feb 08, 2025

William Blair Weighs in on CVRx’s Q2 Earnings (NASDAQ:CVRX) - Defense World

Feb 08, 2025
pulisher
Feb 08, 2025

FY2025 EPS Estimates for CVRx Cut by Cantor Fitzgerald - Defense World

Feb 08, 2025
pulisher
Feb 08, 2025

CVRx (NASDAQ:CVRX) Issues Quarterly Earnings Results - MarketBeat

Feb 08, 2025
pulisher
Feb 07, 2025

CVRX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into BRONSTEIN, GEWIRTZ & GROSSMAN, LLC and Encourages Investors to Contact the Firm Today! - ACCESS Newswire

Feb 07, 2025
pulisher
Feb 07, 2025

Skechers Posts Downbeat Results, Joins e.l.f. Beauty, LiveRamp And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Feb 07, 2025
pulisher
Feb 07, 2025

FY2025 EPS Estimates for CVRx Decreased by Cantor Fitzgerald - Armenian Reporter

Feb 07, 2025
pulisher
Feb 07, 2025

Calamos Advisors LLC Makes New Investment in CVRx, Inc. (NASDAQ:CVRX) - ETF Daily News

Feb 07, 2025
pulisher
Feb 07, 2025

Canaccord Genuity Group Boosts CVRx (NASDAQ:CVRX) Price Target to $23.00 - Defense World

Feb 07, 2025
pulisher
Feb 07, 2025

CVRx targets $63M-$65M revenue in 2025 with strengthened sales strategy - MSN

Feb 07, 2025
pulisher
Feb 07, 2025

Piper Sandler Raises CVRx (NASDAQ:CVRX) Price Target to $20.00 - Defense World

Feb 07, 2025
pulisher
Feb 06, 2025

CVRx Inc [CVRX] Shares Fall -7.20 % on Wednesday - Knox Daily

Feb 06, 2025
pulisher
Feb 06, 2025

Should You Invest in CVRx Inc (CVRX) Now? - The News Heater

Feb 06, 2025
pulisher
Feb 05, 2025

CVRx’s Earnings Call: Growth Amid Challenges - TipRanks

Feb 05, 2025
pulisher
Feb 05, 2025

What 4 Analyst Ratings Have To Say About CVRx - Benzinga

Feb 05, 2025
pulisher
Feb 05, 2025

CVRx stock dips on Q4 EPS miss - Mass Device

Feb 05, 2025
pulisher
Feb 05, 2025

CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

Objective long/short (CVRX) Report - Stock Traders Daily

Feb 05, 2025
pulisher
Feb 04, 2025

CVRx Announces Strong Revenue Growth in 2024 - TipRanks

Feb 04, 2025
pulisher
Feb 04, 2025

CVRx, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 04, 2025
pulisher
Feb 04, 2025

Earnings call transcript: CVRx Q4 2024 shows revenue growth, stock dips - MSN

Feb 04, 2025
pulisher
Feb 04, 2025

CVRx Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 04, 2025
pulisher
Feb 04, 2025

CVRx Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

CVRx: Q4 Earnings Snapshot -February 04, 2025 at 04:50 pm EST - Marketscreener.com

Feb 04, 2025
pulisher
Feb 04, 2025

CVRx: Q4 Earnings Snapshot - Leader-Telegram

Feb 04, 2025
pulisher
Feb 04, 2025

Earnings Flash (CVRX) CVRX INC. Reports Q4 Revenue $15.3M, vs. FactSet Est of $15.1M - Marketscreener.com

Feb 04, 2025
pulisher
Feb 04, 2025

CVRx Earnings Showcase: Heart Failure Treatment Propels 41% Revenue Explosion in Core Market - StockTitan

Feb 04, 2025
pulisher
Feb 04, 2025

CVRx, Inc. (NASDAQ:CVRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Feb 04, 2025
pulisher
Feb 03, 2025

CVRx Inc (CVRX) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Feb 03, 2025

Cvrx Inc Stock (CVRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$107.57
price up icon 3.40%
medical_devices STE
$222.45
price down icon 0.89%
medical_devices PHG
$26.11
price down icon 2.03%
$68.48
price down icon 3.22%
$81.45
price down icon 2.79%
medical_devices EW
$67.95
price down icon 0.82%
Cap:     |  Volume (24h):